SCHEMBL28797215

SCHEMBL28797215

CC(C)c1ccc(C=CCS(=O)(=O)n2c(Cc3ccc(C(=O)O)cc3)cc3cc(Cl)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DHCR7 Q9UBM7 1/20 0.41
▸ PHGDH O43175 1/20 0.40
▸ ACLY P53396 5/20 0.39
▸ EBP Q15125 1/20 0.39
▸ SIGMAR1 Q99720 1/20 0.39
▸ PPARG P37231 6/20 0.36
▸ PPARD Q03181 4/20 0.36
▸ PPARA Q07869 4/20 0.36
▸ ENPP2 Q13822 1/20 0.36
▸ PLA2G4A P47712 2/20 0.35
▸ RXRA P19793 1/20 0.35
▸ RXRB P28702 1/20 0.35
▸ CSNK2A2 P19784 1/20 0.35
▸ CSNK2B P67870 1/20 0.35
▸ CSNK2A1 P68400 1/20 0.35
▸ CSNK2A3 Q8NEV1 1/20 0.35
▸ GRIK1 P39086 1/20 0.34
▸ GRIK2 Q13002 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27884471 0.92 ACLY (0.37) DHCR7PHGDHACLYPPARGPPARD
SCHEMBL27867731 0.91 CCR2 (0.43) PHGDHACLYPPARGPPARDPPARA
SCHEMBL27884364 0.89 DHCR7 (0.42) DHCR7ACLYEBPSIGMAR1PPARG
SCHEMBL28800067 0.88 RORC (0.40) DHCR7PPARGPPARDPPARA
SCHEMBL28946031 0.88 ACLY (0.35) DHCR7PHGDHACLYPPARGPPARD
SCHEMBL27884203 0.88 PPARG (0.34) DHCR7PHGDHACLYPPARGPPARD
SCHEMBL27884355 0.88 PPARG (0.44) DHCR7ACLYEBPSIGMAR1PPARG
SCHEMBL27867728 0.87 ACLY (0.39) DHCR7ACLYEBPSIGMAR1PPARG
SCHEMBL27884477 0.84 PHGDH (0.44) DHCR7PHGDHACLYEBPSIGMAR1
SCHEMBL27713455 0.84 PPARG (0.54) ACLYPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596906-A Use of indole derivatives as NURR-1 activators as agents for the treatment of Parkinson's disease FOURNIER LAB SA 2012-07-18 — — CN disclosed
Send feedback